Stay updated on MOST: Stroke Thrombolysis Clinical Trial
Sign up to get notified when there's something new on the MOST: Stroke Thrombolysis Clinical Trial page.

Latest updates to the MOST: Stroke Thrombolysis Clinical Trial page
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a new Locations section listing all study sites by state (Alabama, California, Connecticut, Florida, Georgia, Illinois, Kansas, Kentucky, Massachusetts, Michigan, Minnesota, Missouri, New Mexico, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia) as part of revision v3.3.3.SummaryDifference2%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedFooter now shows Revision: v3.3.2, replacing Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedEditorial wording now indicates that publications are automatically filled in from PubMed and the revision tag changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedRemoved the site-wide funding-status notice. The MOST study details, eligibility criteria, and outcomes information remain unchanged.SummaryDifference0.2%

- Check70 days agoChange DetectedResults have been posted for the MOST trial, and the study status/dates have been updated (including the last update and completion dates).SummaryDifference0.3%

- Check84 days agoChange DetectedAdded a new prespecified subgroup analysis publication from the MOST Trial (thrombolysis alone vs with Argatroban/Eptifibatide) with full citation and author list. No deletions detected.SummaryDifference2%

Stay in the know with updates to MOST: Stroke Thrombolysis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MOST: Stroke Thrombolysis Clinical Trial page.